Cargando…

Direct economic impact of Chagas disease treatment

Detalles Bibliográficos
Autores principales:	Zaidel, Ezequiel J., Sosa Liprandi, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389032/ https://www.ncbi.nlm.nih.gov/pubmed/35992494 http://dx.doi.org/10.1177/20499361221118227

Ejemplares similares

A recent experience on the role of influenza vaccination on cardiovascular events
por: Sosa-Liprandi, María Inés, et al.
Publicado: (2023)

Roadblocks in Chagas disease care in endemic and nonendemic countries: Argentina, Colombia, Spain, and the United States. The NET-Heart project
por: Miranda-Arboleda, Andrés F., et al.
Publicado: (2021)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide
por: Martinez, Felipe, et al.
Publicado: (2019)

WHF IASC Roadmap on Chagas Disease
por: Echeverría, Luis Eduardo, et al.
Publicado: (2020)

Fragmented QRS and Chagas' disease
por: Baranchuk, Adrian
Publicado: (2014)

Physician Awareness of Chagas Disease, USA
por: Stimpert, Kelly K., et al.
Publicado: (2010)

New Diagnostic Algorithm for Chagas Disease: Impact on Access to Diagnosis and Out-of-Pocket Expenditures in Colombia
por: OLIVERA, Mario J., et al.
Publicado: (2019)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

COVID-19: Implications for People with Chagas Disease
por: Zaidel, Ezequiel José, et al.
Publicado: (2020)

Chagas Disease in Ancient Hunter-Gatherer Population, Brazil
por: Lima, Valdirene S., et al.
Publicado: (2008)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

WHF Recommendations for the Use of Echocardiography in Chagas Disease
por: Ralston, Kate, et al.
Publicado: (2023)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
por: Sampaio, Elieusa e Silva, et al.
Publicado: (2018)

Incidence of Atrial High-Rate Episodes in Chagas Disease Patients
por: Freitas, Emanoela Lima, et al.
Publicado: (2018)

Cord Blood Sample Screening for Evidence of Maternal Chagas Disease
por: Montgomery, Susan P., et al.
Publicado: (2017)

Primer choque apropiado del desfibrilador automático implantable en pacientes con cardiopatía chagásica
por: García-Chamorro, Luis G., et al.
Publicado: (2022)

Cardiac Medications Can Influence the Exercise Prescription in Chagas Heart Disease
por: Cunha, Raphael Martins, et al.
Publicado: (2015)

Reactivation of Chagas-Mazza disease during treatment with infliximab
por: Vacas, Aldana Soledad, et al.
Publicado: (2017)

Potential novel risk factors for autochthonous and sylvatic transmission of human Chagas disease in the United States
por: Garcia, Melissa N, et al.
Publicado: (2014)

Digitizing the direct laryngoscopy experience: the economic way!!
por: Hasija, Neha, et al.
Publicado: (2018)

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

Negative association between right bundle branch block and inducibility of ventricular tachyarrhythmias in Chagas disease
por: Veloso, Henrique Horta
Publicado: (2014)

Response To Letter To The Editor Regarding Article "Repolarization Parameters Are Associated With Mortality In Chagas Disease Patients In The United States"
por: Bradfield, J, et al.
Publicado: (2014)

ECONOMIC IMPACT OF COVID-19
por: MUNGMUNPUNTIPANTIP, RUJITTIKA, et al.
Publicado: (2023)

Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
por: Ramires, Felix J.A., et al.
Publicado: (2018)

Regarding Perspective Piece from July 2016 “What Do We Know About Chagas Disease in the United States?”
por: Nelson, Kenrad E., et al.
Publicado: (2017)

Treatment of Chagas Disease in the United States
por: Meymandi, Sheba, et al.
Publicado: (2018)

Indeterminate Form of Chagas Disease: Some Immunological Insights
por: Matos, Daniel Mazza, et al.
Publicado: (2022)

Comment on “Economic Burden and Medical Insurance Impact of the Different Dialysis for End-Stage Renal Diseases”
por: Bayati, Mohsen
Publicado: (2019)

Congenital Chagas disease: an update
por: Carlier, Yves, et al.
Publicado: (2015)

Critical analysis of Chagas disease treatment in different countries
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2022)

The Impact of Health Insurance on Economic Burden for Hepatitis B Inpatients in China
por: ZHANG, Hua, et al.
Publicado: (2016)

COVID-19, economic impact and child mortality: A global concern
por: Kabir, Mahvish, et al.
Publicado: (2020)

The Impact of Socio-Economic Status on Obesity of Adolescents in the Largest Municipality in the Former Yugoslavia
por: Malovic, Pavle, et al.
Publicado: (2021)

Comprehensive care for patients with Chagas cardiomyopathy during the coronavirus disease pandemic
por: Mazzoli-Rocha, Flavia, et al.
Publicado: (2020)

The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission
por: Bartsch, Sarah M., et al.
Publicado: (2018)

Therapy of Chagas Disease: Implications for Levels of Prevention
por: Sosa-Estani, Sergio, et al.
Publicado: (2012)

Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation
por: Liprandi, Álvaro Sosa, et al.
Publicado: (2021)

Ten Years of Research in the Journal of Family and Economic Issues, and Thoughts on Future Directions
por: Dolan, Elizabeth M.
Publicado: (2020)

Ten Years of Research in the Journal of Family and Economic Issues: Thoughts on Future Directions
por: Dolan, Elizabeth M.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4k1gt713kt4uorco0s5cr5skco